Lisle E. Mose

88.5k total citations
19 papers, 757 citations indexed

About

Lisle E. Mose is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Lisle E. Mose has authored 19 papers receiving a total of 757 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 7 papers in Oncology and 7 papers in Cancer Research. Recurrent topics in Lisle E. Mose's work include Cancer Genomics and Diagnostics (6 papers), Genomics and Phylogenetic Studies (4 papers) and RNA modifications and cancer (4 papers). Lisle E. Mose is often cited by papers focused on Cancer Genomics and Diagnostics (6 papers), Genomics and Phylogenetic Studies (4 papers) and RNA modifications and cancer (4 papers). Lisle E. Mose collaborates with scholars based in United States, Germany and France. Lisle E. Mose's co-authors include Joel S. Parker, Charles M. Perou, Sara R. Selitsky, D. Neil Hayes, Benjamin G. Vincent, Matthew D. Wilkerson, Shengjie Chai, Michael D. Iglesia, Katherine A. Hoadley and Ryoichi Saito and has published in prestigious journals such as Nucleic Acids Research, Nature Communications and Bioinformatics.

In The Last Decade

Lisle E. Mose

19 papers receiving 746 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lisle E. Mose United States 12 386 292 241 152 133 19 757
Roelof J.C. Kluin Netherlands 9 295 0.8× 412 1.4× 128 0.5× 310 2.0× 91 0.7× 12 751
David Brocks Germany 10 584 1.5× 151 0.5× 266 1.1× 78 0.5× 76 0.6× 14 807
Wenzel Vogel Germany 19 444 1.2× 228 0.8× 207 0.9× 90 0.6× 46 0.3× 36 773
Anne‐Lise Børresen‐Dale Norway 11 323 0.8× 315 1.1× 262 1.1× 46 0.3× 76 0.6× 17 627
Joël Gsponer Switzerland 11 213 0.6× 242 0.8× 160 0.7× 185 1.2× 48 0.4× 17 675
Barbara Hutter Germany 16 413 1.1× 160 0.5× 172 0.7× 38 0.3× 180 1.4× 33 751
Jeannine Lacroix Germany 15 253 0.7× 490 1.7× 186 0.8× 39 0.3× 168 1.3× 25 826
Elisa Napolitano Ferreira Brazil 14 354 0.9× 188 0.6× 207 0.9× 46 0.3× 61 0.5× 37 616
Patricia Keith Australia 11 270 0.7× 134 0.5× 139 0.6× 59 0.4× 88 0.7× 15 568
Anshuman Panda United States 10 358 0.9× 424 1.5× 215 0.9× 215 1.4× 23 0.2× 24 844

Countries citing papers authored by Lisle E. Mose

Since Specialization
Citations

This map shows the geographic impact of Lisle E. Mose's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lisle E. Mose with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lisle E. Mose more than expected).

Fields of papers citing papers by Lisle E. Mose

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lisle E. Mose. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lisle E. Mose. The network helps show where Lisle E. Mose may publish in the future.

Co-authorship network of co-authors of Lisle E. Mose

This figure shows the co-authorship network connecting the top 25 collaborators of Lisle E. Mose. A scholar is included among the top collaborators of Lisle E. Mose based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lisle E. Mose. Lisle E. Mose is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Vincent, Benjamin G., Michael D. Iglesia, Shengjie Chai, et al.. (2024). Claudin-low bladder tumors are immune infiltrated and actively immune suppressed. UNC Libraries. 1 indexed citations
2.
Marron, J. S., et al.. (2023). Translating transcriptomic findings from cancer model systems to humans through joint dimension reduction. Communications Biology. 6(1). 179–179. 4 indexed citations
3.
Damrauer, Jeffrey S., Vonn Walter, Aatish Thennavan, et al.. (2021). Genomic characterization of rare molecular subclasses of hepatocellular carcinoma. Communications Biology. 4(1). 1150–1150. 5 indexed citations
4.
Lou, Jitong, Yang Yang, Qisheng Gu, et al.. (2021). Rad18 mediates specific mutational signatures and shapes the genomic landscape of carcinogen-induced tumorsin vivo. NAR Cancer. 3(1). zcaa037–zcaa037. 11 indexed citations
5.
Simpson, Dennis A., Rashmi J. Kumar, Luciano G. Martelotto, et al.. (2020). A P53-Independent DNA Damage Response Suppresses Oncogenic Proliferation and Genome Instability. Cell Reports. 30(5). 1385–1399.e7. 22 indexed citations
6.
Selitsky, Sara R., David Marron, Daniel P. Hollern, et al.. (2020). Virus expression detection reveals RNA-sequencing contamination in TCGA. BMC Genomics. 21(1). 79–79. 20 indexed citations
7.
Hoadley, Katherine A., Bradford C. Powell, Dona Kanavy, et al.. (2020). Abstract P4-05-03: Mutational analysis of triple-negative breast cancer (TNBC): CALGB 40603 (Alliance). Cancer Research. 80(4_Supplement). P4–5. 2 indexed citations
8.
Feng, Wanjuan, Dennis A. Simpson, Juan Carvajal-Garcia, et al.. (2019). Genetic determinants of cellular addiction to DNA polymerase theta. Nature Communications. 10(1). 4286–4286. 110 indexed citations
9.
Selitsky, Sara R., Lisle E. Mose, Christof C. Smith, et al.. (2019). Prognostic value of B cells in cutaneous melanoma. Genome Medicine. 11(1). 36–36. 83 indexed citations
10.
Mose, Lisle E., Charles M. Perou, & Joel S. Parker. (2019). Improved indel detection in DNA and RNA via realignment with ABRA2. Bioinformatics. 35(17). 2966–2973. 41 indexed citations
11.
Selitsky, Sara R., David Marron, Lisle E. Mose, Joel S. Parker, & Dirk P. Dittmer. (2018). Epstein-Barr Virus-Positive Cancers Show Altered B-Cell Clonality. mSystems. 3(5). 15 indexed citations
12.
Silva, Grace O., Marni B. Siegel, Lisle E. Mose, et al.. (2017). SynthEx: a synthetic-normal-based DNA sequencing tool for copy number alteration detection and tumor heterogeneity profiling. Genome biology. 18(1). 66–66. 19 indexed citations
13.
Mose, Lisle E., D. Neil Hayes, Charles M. Perou, & Joel S. Parker. (2017). Abstract 3592: Improved indel detection in RNA-seq data via assembly based re-alignment reveals expressed Epidermal Growth Factor Receptor indels in Lung Adenocarcinoma. Cancer Research. 77(13_Supplement). 3592–3592. 7 indexed citations
14.
Chai, Shengjie, Lisle E. Mose, Sara R. Selitsky, et al.. (2016). Claudin-low bladder tumors are immune infiltrated and actively immune suppressed. JCI Insight. 1(3). e85902–e85902. 149 indexed citations
15.
Mose, Lisle E., Sara R. Selitsky, Lisa M. Bixby, et al.. (2016). Assembly-based inference of B-cell receptor repertoires from short read RNA sequencing data with V’DJer. Bioinformatics. 32(24). 3729–3734. 45 indexed citations
16.
Seifert, Bryce A., Julianne O’Daniel, Daniel S. Marchuk, et al.. (2016). Germline Analysis from Tumor–Germline Sequencing Dyads to Identify Clinically Actionable Secondary Findings. Clinical Cancer Research. 22(16). 4087–4094. 63 indexed citations
17.
Traina, Tiffany A., Ayca Gucalp, William R. Polkinghorn, et al.. (2015). Abstract P3-04-01: Whole transcriptome analysis of AR+ ER/PR- metastatic breast cancers treated with bicalutamide on TBCRC011. Cancer Research. 75(9_Supplement). P3–4. 1 indexed citations
18.
Wilkerson, Matthew D., Christopher R. Cabanski, Wei Sun, et al.. (2014). Integrated RNA and DNA sequencing improves mutation detection in low purity tumors. Nucleic Acids Research. 42(13). e107–e107. 53 indexed citations
19.
Mose, Lisle E., Matthew D. Wilkerson, D. Neil Hayes, Charles M. Perou, & Joel S. Parker. (2014). ABRA: improved coding indel detection via assembly-based realignment. Bioinformatics. 30(19). 2813–2815. 106 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026